DSGN
Price
$4.19
Change
+$0.22 (+5.54%)
Updated
Aug 8, 10:31 AM (EDT)
Capitalization
225.37M
89 days until earnings call
JSPR
Price
$2.67
Change
-$0.07 (-2.56%)
Updated
Aug 8, 11:52 AM (EDT)
Capitalization
41.01M
Interact to see
Advertisement

DSGN vs JSPR

Header iconDSGN vs JSPR Comparison
Open Charts DSGN vs JSPRBanner chart's image
Design Therapeutics
Price$4.19
Change+$0.22 (+5.54%)
Volume$100
Capitalization225.37M
Jasper Therapeutics
Price$2.67
Change-$0.07 (-2.56%)
Volume$200
Capitalization41.01M
DSGN vs JSPR Comparison Chart in %
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. JSPR commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and JSPR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (DSGN: $3.97 vs. JSPR: $2.73)
Brand notoriety: DSGN and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 68% vs. JSPR: 47%
Market capitalization -- DSGN: $225.37M vs. JSPR: $41.01M
DSGN [@Biotechnology] is valued at $225.37M. JSPR’s [@Biotechnology] market capitalization is $41.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, JSPR is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while JSPR’s TA Score has 5 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 4 bearish.
  • JSPR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both DSGN and JSPR are a good buy in the short-term.

Price Growth

DSGN (@Biotechnology) experienced а +2.58% price change this week, while JSPR (@Biotechnology) price change was -5.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

DSGN is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($225M) has a higher market cap than JSPR($41M). DSGN YTD gains are higher at: -35.656 vs. JSPR (-87.231). DSGN has higher annual earnings (EBITDA): -67.79M vs. JSPR (-81.61M). DSGN has more cash in the bank: 230M vs. JSPR (48.8M). DSGN has less debt than JSPR: DSGN (2.14M) vs JSPR (2.59M). DSGN (0) and JSPR (0) have equivalent revenues.
DSGNJSPRDSGN / JSPR
Capitalization225M41M549%
EBITDA-67.79M-81.61M83%
Gain YTD-35.656-87.23141%
P/E RatioN/AN/A-
Revenue00-
Total Cash230M48.8M471%
Total Debt2.14M2.59M83%
TECHNICAL ANALYSIS
Technical Analysis
DSGNJSPR
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SELX1.080.04
+3.85%
Semilux International Ltd
CARE17.09-0.10
-0.58%
Carter Bankshares
GS719.74-5.00
-0.69%
Goldman Sachs Group
OMF55.61-0.81
-1.44%
OneMain Holdings
MMI28.74-3.49
-10.83%
Marcus & Millichap

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-8.74%
VRDN - DSGN
49%
Loosely correlated
-3.90%
IDYA - DSGN
49%
Loosely correlated
-5.16%
AURA - DSGN
46%
Loosely correlated
-1.21%
TRDA - DSGN
46%
Loosely correlated
-10.92%
NTLA - DSGN
45%
Loosely correlated
+0.88%
More